Skip to main content
. 2022 Oct 10;147(5-6):486–496. doi: 10.1159/000527459

Fig. 2.

Fig. 2

Odds ratio (OR) for any bleeding complication in patients treated with ticagrelor versus clopidogrel (<1 favors ticagrelor). Crude and propensity score-adjusted OR and 95% confidence intervals are presented for the whole population, the subgroup undergoing percutaneous coronary intervention (PCI) ad hoc and the subgroup undergoing coronary angiography (CA) only.